# Lifecore Biomedical, Inc. \\de\\: Form 10-KT, filed Mar 16, 2026

- Company: [Lifecore Biomedical, Inc. \\de\\](/companies/lfcr.md) (CIK 1005286)
- Form: 10-KT
- Filed: 2026-03-16
- Accepted by EDGAR: Mar 16, 2026, 08:15 ET
- Period: 2025-12-31
- Accession: 0001005286-26-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1005286/000100528626000009/lfcr-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1005286/000100528626000009/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cash and equivalents | at 2025-12-31 | $17.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $82.3m | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $232.2m | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $23.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-12-31 | $198.1m | us-gaap:Liabilities |
| Long-term debt | at 2025-12-31 | $142.2m | us-gaap:LongTermDebt |
| Current portion of debt | at 2025-12-31 | $954.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2025-12-31 | −$14.2m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1005286/000100528626000009/lfcr-20251231.htm

Filed Mar 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001005286-26-000009. Last ingested by Listed: Nov 4, 2026, 07:35 ET. No prices; not investment advice.